Defining “Adequately Treated”: A Post Hoc Analysis Examining Characteristics of Patients with Schizophrenia Successfully Transitioned from Once-Monthly Paliperidone Palmitate to Once-Every-3-Months Paliperidone Palmitate

PURPOSE: Paliperidone palmitate once every 3 months (PP3M) is indicated in adults with schizophrenia adequately treated with once-monthly paliperidone palmitate (PP1M) for at least 4 months, in whom the last two consecutive doses are the same. The decision of when to transition to PP3M is based on t...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Donnell, Amy, Rao, Sanjai, Turkoz, Ibrahim, Gopal, Srihari, Kim, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797315/
https://www.ncbi.nlm.nih.gov/pubmed/33442251
http://dx.doi.org/10.2147/NDT.S278298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797315/
https://www.ncbi.nlm.nih.gov/pubmed/33442251
http://dx.doi.org/10.2147/NDT.S278298

Ejemplares similares